| Catalog Number | orb61065 |
|---|---|
| CAS Number | 641571-10-0 |
| Application notes | BNL |
| Note | For research use only. |
| Expiration Date | 12 months from date of receipt. |
| Description | Nilotinib (AMN-107, Tasigna) is a Bcr-Abl inhibitor with IC50 less than 30 nM. Nilotinib has entered in a phase IV clinical trial in the treatment of philadelphia chromosome positive and chronic myelogenous leukemia in chronic phase. Nilotinib is a selective inhibitor of native and mutant Bcr-Abl. |
Chemical structure of Nilotinib, Free Base
Nilotinib, Free Base: Tasigna, AMN107, AMN 107
